<DOC>
	<DOCNO>NCT02928939</DOCNO>
	<brief_summary>Clinical practice guideline take account multimorbidity various potential therapeutic conflict . Identifying quantify therapeutic conflict crucial multimorbid patient two acute chronic disease . Guidance available frequent encounter situation , e.g . gastrointestinal bleeding exacerbation diabetes mellitus .</brief_summary>
	<brief_title>Therapeutic Conflicts Multimorbidity</brief_title>
	<detailed_description>The study investigate multimorbidity view occurrence two different therapeutic conflict dilemma situation , respectively . The first concern patient diagnosis gastrointestinal bleeding prescription anticoagulant or/and antiplatelet drug ( e.g. , warfarin , clopidogrel acetylsalicylic acid ) risk factor bleed event . The second concern patient diagnosis exacerbate diabetes mellitus prescription corticosteroid risk factor worsen blood glucose .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Diabetes Complications</mesh_term>
	<mesh_term>Gastrointestinal Hemorrhage</mesh_term>
	<criteria>Inpatients University Hospital Zurich , USZ Male female patient , age 18 year old Fulfilling criterion Use Case A B ( i.e . patient gastrointestinal bleed anticoagulant antiplatelet drug , Use Case A patient diabetes mellitus and/or systemic corticosteroid , Use Case B ) If potential participant statement electronic medical record elsewhere refuse study participation , represent exclusion criterion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>multimorbidity</keyword>
	<keyword>multiple chronic condition</keyword>
	<keyword>drug-drug interaction</keyword>
	<keyword>drug-disease interaction</keyword>
	<keyword>polypharmacy</keyword>
	<keyword>Oral anticoagulant</keyword>
	<keyword>Steroids</keyword>
</DOC>